Martin Dayton, DO - LDN Case Studies (2016 Conference) (LDN, low dose naltrexone)
Dr Martin Dayton shares three case studies of patients suffering from follicular B-cell non Hodgkin's Lymphoma who were treated with nothing more than Low Dose Naltrexone (LDN).
Case 1: An 82-year old man who had been treated elsewhere for B-cell non Hodgkin's Lymphoma and had been placed in hospice care by mainstream medicine. His family called Dr Dayton stating he wanted Dr Dayton to treat him but he didn’t want to spend a lot of money or travel to his office or take a “Bunch of pills”. Dr Dayton sent the patient a prescription for Low Dose Naltrexone. Eight weeks later he received a call from the family to tell him the patient was now enjoying ballroom dancing! From hospice to ballroom was an excellent result but for reasons of his own the patient stopped LDN after several months and sadly passed away. LDN was a choice given to the patient for as long as he wanted it.
Case 2 A lady in her fifties, she had tumors grotesquely protruding from her head, neck, torso, her abdomen was extended with hard masses. Before seeing Dr Dayton this lady had been seen by the Mayo clinic who offered chemotherapy and radiation which she refused. Initially Dr Dayton treated this lady with intravenous vitamin C and ozone. He then put her on low dose naltrexone as her only therapy. She maintained a job with adequate energy for over two years, grotesque masses and all. A modest regression in the tumours occurred. One day, she visited Dr Dayton’s office in a wheelchair with paresis of her lower extremities. She had stopped taking low dose naltrexone three months before for economical reasons. A tumor had grown into her spine exerting pressure on the spinal cord, leading to a loss of motor function of the lower extremities. Dr Dayton sent her to the local hospital immediately to receive radiation of the involved tumor. The radiation was successful and function returned but she embraced her new mainstream doctors who unfortunately did not continue her low dose naltrexone. She expired a few months later. Dr Dayton believed that had she continued LDN she might have lived.
Case 3: A 46 year old lady diagnosed with follicular lymphoma in 2011. She had occasional ozone therapy, but no drugs. In March 2012, a PET CT demonstrated multiple enlarged metabolically active lymph nodes involving her immediate steinem, her abdomen and her neck. LDN was initiated. In October 2013, over a year later, scanning demonstrated a mild increase in cancer activity. In 2014 she initiated Gerson therapy, while on LDN. Dr Dayton says that Gerson therapy is still controversial - the benefits remaining inclusive. The prescription of LDN was continued into 2015. In 2015, the patient concluded the LDN is an unnatural toxin and consequently stopped the use of LDN. Later in 2015, no traces of cancer with pet scanning were found and the patient was in clinical remission. The patient believes that it was Gerson therapy, not LDN that brought about her remission. Dr Dayton concludes that it was LDN more likely in his opinion, or it was a synergistic combination of the two using a holistic approach with LDN.
Dr Dayton offers Low Dose Naltrexone to all of his patients who have a history of B-cell non Hodgkin's lymphoma, as well as other applicable conditions, providing they have no contraindications to using it.
For more conference presentations please visit https://ldnresearchtrust.org/ldn-conferences